Matches in SemOpenAlex for { <https://semopenalex.org/work/W4236026741> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4236026741 endingPage "i" @default.
- W4236026741 startingPage "i" @default.
- W4236026741 abstract "For extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae infections, carbapenems are recommended as first line therapy, and clinical data on the therapeutic efficacy of fluoroquinolones (FQs) is limited. This study compares the efficacy of FQs and carbapenems for bloodstream infections caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae.Between 2008 and 2010, adults with ESBL-producing E. coli or K. pneumoniae bacteremia at two medical centers were reviewed. Adults receiving definitive FQ or carbapenem therapy were compared in a propensity score-matched analysis, and 30-day mortality was the primary endpoint.A total of 299 patients were eligible. Patients receiving a FQ (n = 24), either ciprofloxacin or levofloxacin, had a lower 30-day mortality rate than those with carbapenem therapy (8.3%, 2/24 vs. 23.3%, 64/275; p = 0.12). Multivariate regression analysis revealed that a critical illness [Pitt bacteremia score ≥ 4 points; odds ratio (OR), 7.09; p < 0.001], rapidly fatal underlying disease (OR, 5.73; p < 0.001), and hospital-associated infection (OR, 2.57; p = 0.01) were independently associated with 30-day mortality. By contrast, FQ definitive therapy was a protective factor compared with carbapenems (OR, 0.18; p = 0.04). There were 72 matched cases with carbapenem therapy in a propensity score-matched analysis, and a difference in the 30-day mortality rate of two groups was noted (8.3% vs. 29.2%; p = 0.05).For ESBL-producing E. coli or K. pneumoniae bacteremia, ciprofloxacin or levofloxacin, if active in vitro, can be considered as a carbapenem-sparing alternative." @default.
- W4236026741 created "2022-05-12" @default.
- W4236026741 creator A5011739266 @default.
- W4236026741 creator A5023341317 @default.
- W4236026741 date "2017-07-01" @default.
- W4236026741 modified "2023-09-25" @default.
- W4236026741 title "Atopic Dermatitis" @default.
- W4236026741 doi "https://doi.org/10.1016/s0733-8635(17)30058-x" @default.
- W4236026741 hasPublicationYear "2017" @default.
- W4236026741 type Work @default.
- W4236026741 citedByCount "4" @default.
- W4236026741 countsByYear W42360267412017 @default.
- W4236026741 countsByYear W42360267412021 @default.
- W4236026741 countsByYear W42360267412022 @default.
- W4236026741 crossrefType "journal-article" @default.
- W4236026741 hasAuthorship W4236026741A5011739266 @default.
- W4236026741 hasAuthorship W4236026741A5023341317 @default.
- W4236026741 hasConcept C104317684 @default.
- W4236026741 hasConcept C126322002 @default.
- W4236026741 hasConcept C156957248 @default.
- W4236026741 hasConcept C168563851 @default.
- W4236026741 hasConcept C179755657 @default.
- W4236026741 hasConcept C185592680 @default.
- W4236026741 hasConcept C203092338 @default.
- W4236026741 hasConcept C2776685102 @default.
- W4236026741 hasConcept C2777058267 @default.
- W4236026741 hasConcept C2778512257 @default.
- W4236026741 hasConcept C2779443120 @default.
- W4236026741 hasConcept C2781276175 @default.
- W4236026741 hasConcept C3019249092 @default.
- W4236026741 hasConcept C501593827 @default.
- W4236026741 hasConcept C547475151 @default.
- W4236026741 hasConcept C55493867 @default.
- W4236026741 hasConcept C71924100 @default.
- W4236026741 hasConcept C86803240 @default.
- W4236026741 hasConcept C89423630 @default.
- W4236026741 hasConcept C90924648 @default.
- W4236026741 hasConceptScore W4236026741C104317684 @default.
- W4236026741 hasConceptScore W4236026741C126322002 @default.
- W4236026741 hasConceptScore W4236026741C156957248 @default.
- W4236026741 hasConceptScore W4236026741C168563851 @default.
- W4236026741 hasConceptScore W4236026741C179755657 @default.
- W4236026741 hasConceptScore W4236026741C185592680 @default.
- W4236026741 hasConceptScore W4236026741C203092338 @default.
- W4236026741 hasConceptScore W4236026741C2776685102 @default.
- W4236026741 hasConceptScore W4236026741C2777058267 @default.
- W4236026741 hasConceptScore W4236026741C2778512257 @default.
- W4236026741 hasConceptScore W4236026741C2779443120 @default.
- W4236026741 hasConceptScore W4236026741C2781276175 @default.
- W4236026741 hasConceptScore W4236026741C3019249092 @default.
- W4236026741 hasConceptScore W4236026741C501593827 @default.
- W4236026741 hasConceptScore W4236026741C547475151 @default.
- W4236026741 hasConceptScore W4236026741C55493867 @default.
- W4236026741 hasConceptScore W4236026741C71924100 @default.
- W4236026741 hasConceptScore W4236026741C86803240 @default.
- W4236026741 hasConceptScore W4236026741C89423630 @default.
- W4236026741 hasConceptScore W4236026741C90924648 @default.
- W4236026741 hasIssue "3" @default.
- W4236026741 hasLocation W42360267411 @default.
- W4236026741 hasOpenAccess W4236026741 @default.
- W4236026741 hasPrimaryLocation W42360267411 @default.
- W4236026741 hasRelatedWork W1877476828 @default.
- W4236026741 hasRelatedWork W2047676501 @default.
- W4236026741 hasRelatedWork W2077127017 @default.
- W4236026741 hasRelatedWork W2091333504 @default.
- W4236026741 hasRelatedWork W2129824469 @default.
- W4236026741 hasRelatedWork W2145141660 @default.
- W4236026741 hasRelatedWork W2151077670 @default.
- W4236026741 hasRelatedWork W2252508986 @default.
- W4236026741 hasRelatedWork W2409709769 @default.
- W4236026741 hasRelatedWork W2588933041 @default.
- W4236026741 hasVolume "35" @default.
- W4236026741 isParatext "false" @default.
- W4236026741 isRetracted "false" @default.
- W4236026741 workType "article" @default.